Home » Topics » Regulatory » Patents

Patents
RSS

Novel NLRP3 agonists presented by IFM Therapeutics

Nov. 8, 2017

Merck & Co. presents compounds for HCV infection treatment

Nov. 8, 2017

Shenzhen Targetrx Biotechnology identifies PARP inhibitors

Nov. 8, 2017

AstraZeneca patents new ERalpha antagonists and SERDs

Nov. 8, 2017

Boehringer Ingelheim discloses orexin OX1 receptor antagonists

Nov. 7, 2017

Bristol-Myers Squibb presents ROM-K channel blockers for hypertension

Nov. 7, 2017

KRICT presents NAE1 and SAE inhibitors for cancer

Nov. 6, 2017

McGill University discloses ARK-1 and PKC-alpha inhibitors

Nov. 6, 2017

AstraZeneca identifies ERalpha antagonists and SERDs

Nov. 6, 2017

Ono Pharmaceutical divulges novel voltage-gated channel activators

Nov. 6, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...